• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Racial and ethnic disparities in eligibility for postpartum venous thromboembolism prophylaxis in the United States.美国产后静脉血栓栓塞症预防治疗中存在的种族和民族差异。
J Thromb Haemost. 2024 Feb;22(2):545-552. doi: 10.1016/j.jtha.2023.10.004. Epub 2023 Oct 13.
2
Guideline-based venous thromboprophylaxis in postpartum women: An in-depth evaluation of ACOG and RCOG recommendations and real-life implementation.产后女性基于指南的静脉血栓预防:对美国妇产科医师学会(ACOG)和英国皇家妇产科医师学院(RCOG)建议及实际应用的深入评估
Eur J Obstet Gynecol Reprod Biol. 2024 Aug;299:272-277. doi: 10.1016/j.ejogrb.2024.06.027. Epub 2024 Jun 18.
3
Venous thromboembolism incidence among patients recommended for pharmacologic thromboembolism prophylaxis after cesarean delivery in selected guidelines.在选定的指南中,推荐接受剖宫产术后药物血栓预防的患者中静脉血栓栓塞症的发生率。
J Thromb Haemost. 2021 Mar;19(3):830-838. doi: 10.1111/jth.15218. Epub 2021 Jan 17.
4
Postpartum Pharmacologic Thromboprophylaxis and Venous Thromboembolism in a U.S. Cohort.美国队列中产后药物性血栓预防与静脉血栓栓塞
Obstet Gynecol. 2025 Mar 1;145(3):265-272. doi: 10.1097/AOG.0000000000005828. Epub 2025 Jan 16.
5
Estimating the risk thresholds used by guidelines to recommend postpartum thromboprophylaxis.评估指南用于推荐产后血栓预防的风险阈值。
J Thromb Haemost. 2021 Feb;19(2):452-459. doi: 10.1111/jth.15166. Epub 2020 Dec 17.
6
Racial and ethnic differences in the risk of postpartum venous thromboembolism: a population-based, case-control study.种族和民族差异与产后静脉血栓栓塞风险:基于人群的病例对照研究。
J Thromb Haemost. 2014 Dec;12(12):2002-9. doi: 10.1111/jth.12747. Epub 2014 Nov 14.
7
Postpartum pharmacologic thromboprophylaxis and complications in a US cohort.美国队列中的产后药物性血栓预防与并发症。
Am J Obstet Gynecol. 2024 Jul;231(1):128.e1-128.e11. doi: 10.1016/j.ajog.2023.11.013. Epub 2024 Feb 12.
8
Risk Assessment Model for Postpartum Venous Thromboembolism Prevention in Patients with Systemic Lupus Erythematosus.系统性红斑狼疮患者产后静脉血栓栓塞症预防的风险评估模型。
Am J Perinatol. 2023 Dec;40(16):1732-1737. doi: 10.1055/s-0043-1771049. Epub 2023 Jul 20.
9
Projected impact of guidelines on incidence of venous thromboembolism after cesarean delivery in the United States.指南对美国剖宫产术后静脉血栓栓塞发生率的预计影响。
J Thromb Haemost. 2023 Dec;21(12):3547-3556. doi: 10.1016/j.jtha.2023.08.010. Epub 2023 Aug 31.
10
A comparison of recommendations for pharmacologic thromboembolism prophylaxis after caesarean delivery from three major guidelines.三大指南关于剖宫产术后药物性血栓栓塞预防建议的比较
BJOG. 2016 Dec;123(13):2157-2162. doi: 10.1111/1471-0528.13706. Epub 2015 Oct 5.

引用本文的文献

1
Inpatient pharmacological thromboprophylaxis in the antepartum period: an argument for risk-based thromboprophylaxis.孕期住院患者的药物性血栓预防:基于风险的血栓预防的依据
Am J Obstet Gynecol MFM. 2025 Mar;7(1S):101567. doi: 10.1016/j.ajogmf.2024.101567. Epub 2024 Nov 24.

本文引用的文献

1
Why Equitable Access to Vaginal Birth Requires Abolition of Race-Based Medicine.为什么公平获得阴道分娩需要废除基于种族的医学。
AMA J Ethics. 2022 Mar 1;24(3):E233-238. doi: 10.1001/amajethics.2022.233.
2
Prevention and management of venous thromboembolism in pregnancy: cutting through the practice variation.妊娠期静脉血栓栓塞症的预防和管理:消除实践差异。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):559-569. doi: 10.1182/hematology.2021000291.
3
Racial and Ethnic Inequities in Cesarean Birth and Maternal Morbidity in a Low-Risk, Nulliparous Cohort.低危初产妇中剖宫产术与产妇发病率的种族和民族差异。
Obstet Gynecol. 2022 Jan 1;139(1):73-82. doi: 10.1097/AOG.0000000000004620.
4
Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals.医学与科学期刊中种族与民族报告的更新指南。
JAMA. 2021 Aug 17;326(7):621-627. doi: 10.1001/jama.2021.13304.
5
Prediction of vaginal birth after cesarean delivery in term gestations: a calculator without race and ethnicity.预测足月妊娠经剖宫产分娩后阴道分娩的可能性:一个不考虑种族和民族的计算器。
Am J Obstet Gynecol. 2021 Dec;225(6):664.e1-664.e7. doi: 10.1016/j.ajog.2021.05.021. Epub 2021 May 24.
6
Incidence of Venous Thromboembolism in a Racially Diverse Population of Oklahoma County, Oklahoma.俄克拉荷马州俄克拉荷马县不同种族人群的静脉血栓栓塞发生率。
Thromb Haemost. 2021 Jun;121(6):816-825. doi: 10.1055/s-0040-1722189. Epub 2021 Jan 10.
7
Venous thromboembolism incidence among patients recommended for pharmacologic thromboembolism prophylaxis after cesarean delivery in selected guidelines.在选定的指南中,推荐接受剖宫产术后药物血栓预防的患者中静脉血栓栓塞症的发生率。
J Thromb Haemost. 2021 Mar;19(3):830-838. doi: 10.1111/jth.15218. Epub 2021 Jan 17.
8
Does race or ethnicity play a role in the origin, pathophysiology, and outcomes of preeclampsia? An expert review of the literature.种族或民族在先兆子痫的起源、病理生理学及预后中起作用吗?文献综述
Am J Obstet Gynecol. 2022 Feb;226(2S):S876-S885. doi: 10.1016/j.ajog.2020.07.038. Epub 2020 Jul 24.
9
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.美国血液学会 2018 年静脉血栓栓塞症管理指南:妊娠相关静脉血栓栓塞症。
Blood Adv. 2018 Nov 27;2(22):3317-3359. doi: 10.1182/bloodadvances.2018024802.
10
ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy.美国妇产科医师学会实践公告第 196 号:妊娠期血栓栓塞症。
Obstet Gynecol. 2018 Jul;132(1):e1-e17. doi: 10.1097/AOG.0000000000002706.

美国产后静脉血栓栓塞症预防治疗中存在的种族和民族差异。

Racial and ethnic disparities in eligibility for postpartum venous thromboembolism prophylaxis in the United States.

机构信息

Duke University School of Medicine, Durham, North Carolina, USA.

Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Canada.

出版信息

J Thromb Haemost. 2024 Feb;22(2):545-552. doi: 10.1016/j.jtha.2023.10.004. Epub 2023 Oct 13.

DOI:10.1016/j.jtha.2023.10.004
PMID:37838240
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10872622/
Abstract

BACKGROUND

Postpartum venous thromboembolism (VTE) incidence differs by race and ethnicity in the United States. However, it is unclear whether the eligibility criteria for postpartum VTE prophylaxis mirror this disparity.

OBJECTIVE

To characterize the prevalence of risk factors and eligibility for postpartum VTE prophylaxis, among US Birthing people, stratified by race and ethnicity.

METHODS

We analyzed the National Inpatient Sample from October 2015 to December 2019, using diagnosis and procedure codes to identify postpartum individuals and their VTE risk factors. We compared proportion of delivery hospitalizations meeting eligibility for thromboprophylaxis stratified by race or ethnicity, according to American College of Gynecology and Obstetrics, American College of Chest Physicians, Royal College of Obstetricians and Gynecologists (RCOG), and American Society for Hematology guidelines.

RESULTS

Among a national estimate of 14 967 861 delivery hospitalizations in the United States, the proportion of individuals eligible for thromboprophylaxis using the RCOG, American College of Chest Physicians, American College of Gynecology and Obstetrics, and American Society for Hematology guidelines were 32.9%, 8.0%, 0.2%, and 0.2%, respectively. Using the RCOG criteria, non-Hispanic Black individuals had the highest proportion of thromboprophylaxis eligibility (39.7%), whereas it was lowest among Hispanic individuals (30.8%). Racial disparities in thromboprophylaxis eligibility were driven by differences in clinical risk factors (38.8% non-Hispanic Black population vs 30.5% Hispanic population) and cesarean section rates (35.9% vs 32.2%), rather than history of VTE (0.3% vs 0.1%), inherited thrombophilia (0.2% vs 0.2%), or sickle cell disease (0.4% vs <0.1%).

CONCLUSION

Non-Hispanic Black individuals were most likely to qualify for postpartum thromboprophylaxis, attributable to clinical risk factors rather than inherited risk factors. An urgent need exists to better understand ethno-racial disparities in thromboprophylaxis use and to equitably address modifiable risk factors for postpartum VTE.

摘要

背景

在美国,产后静脉血栓栓塞症(VTE)的发病率因种族和民族而异。然而,产后 VTE 预防的资格标准是否反映了这种差异尚不清楚。

目的

根据种族和民族,描述美国分娩人群中产后 VTE 预防的风险因素和资格的流行情况。

方法

我们使用诊断和程序代码分析了 2015 年 10 月至 2019 年 12 月的全国住院患者样本,以确定产后个体及其 VTE 风险因素。我们比较了根据美国妇产科学院、美国胸科医师学会、皇家妇产科医师学院(RCOG)和美国血液学会指南,按种族或民族分层的符合血栓预防条件的分娩住院比例。

结果

在美国全国估计的 14967861 例分娩住院中,符合 RCOG、美国胸科医师学会、美国妇产科学院和美国血液学会指南的血栓预防条件的个体比例分别为 32.9%、8.0%、0.2%和 0.2%。根据 RCOG 标准,非西班牙裔黑人的血栓预防资格比例最高(39.7%),而西班牙裔人的比例最低(30.8%)。血栓预防资格的种族差异是由临床风险因素(非西班牙裔黑人 38.8%,西班牙裔 30.5%)和剖宫产率(35.9% vs 32.2%)的差异驱动的,而不是 VTE 病史(0.3% vs 0.1%)、遗传性血栓形成倾向(0.2% vs 0.2%)或镰状细胞病(0.4% vs <0.1%)。

结论

非西班牙裔黑人最有可能获得产后血栓预防资格,这归因于临床风险因素,而不是遗传风险因素。迫切需要更好地了解产后 VTE 预防中种族差异的原因,并公平地解决产后 VTE 的可改变风险因素。